Chemoinformaics analysis of (4S)-4-(2-HYDROXYPROPAN-2-YL)CYCLOHEXENE-1-CARBOXYLIC ACID
| Molecular Weight | 184.235 | nRot | 2 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 29 |
| Exact Molecular Weight | 184.11 | nRing | 1 |
| Solubility: LogS | -5.075 | nHRing | 0 |
| Solubility: LogP | 2.799 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 29.7747 |
| nHD | 2 | BPOL | 16.9193 |
| QED | 0.823 |
| Synth | 3.842 |
| Natural Product Likeliness | 1.164 |
| NR-PPAR-gamma | 0 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.891 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -5.081 |
| MDCK | 0.0000694 |
| BBB | 0.134 |
| PPB | 0.984302 |
| VDSS | 0.847 |
| FU | 0.0245876 |
| CYP1A2-inh | 0.648 |
| CYP1A2-sub | 0.24 |
| CYP2c19-inh | 0.958 |
| CYP2c19-sub | 0.447 |
| CYP2c9-inh | 0.5 |
| CYP2c9-sub | 0.875 |
| CYP2d6-inh | 0.982 |
| CYP2d6-sub | 0.926 |
| CYP3a4-inh | 0.97 |
| CYP3a4-sub | 0.344 |
| CL | 16.639 |
| T12 | 0.084 |
| hERG | 0.165 |
| Ames | 0.885 |
| ROA | 0.049 |
| SkinSen | 0.375 |
| Carcinogencity | 0.934 |
| EI | 0.252 |
| Respiratory | 0.284 |
| NR-Aromatase | 0.279 |
| Antiviral | No |
| Prediction | 0.943707 |